MedTrace Logo

Testing an Intervention in Irritative Contact Dermatitis

NCT06189144 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-01-03

No results posted yet for this study

Summary

An eczematous reaction is an inflammatory intolerance response of the skin. In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness, itchiness and lichenification. Irritative contact dermatitis describes these patterns of reaction in response to toxicity of chemicals on the skin cells, which trigger inflammation by activation of the innate immune system.

Conditions

  • Contact Dermatitis
  • Contact Dermatitis Irritant

Interventions

OTHER

Emollient cream treatment

Rilastil Difesa Sterile cream

OTHER

no treatment

no treatment

Sponsors & Collaborators

  • University of Split, School of Medicine

    lead OTHER

Principal Investigators

  • josipa bukic · University of Split, School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-06-01
Completion
2024-06-01

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06189144 on ClinicalTrials.gov